Delivery Order SPE2DE24D0013-SPE2D626F00DU
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a delivery order valued at $3,240 from the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with ultimate completion targeted for November 7, 2025. This firm fixed-price delivery order, issued under contract 4569883320 (GXTV-10), carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,500.00 by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This firm fixed-price delivery order, classified as contract number GXMRSA-NXG-10, carries no set-aside designation and represents a continuation of the government's established relationship with Cepheid as a primary federal supplier of molecular diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,182.80 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order, designated as XPRS4PLEX-10, was issued without a set-aside designation and represents a child contract under a larger indefinite delivery vehicle. The order calls for delivery of diagnostic reagents and test kits—specifically...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a firm fixed-price delivery order valued at $1,104.00 by the Defense Logistics Agency Medical Supply Chain, with an award date of November 25, 2025, and ultimate completion date of December 3, 2025. The delivery order, designated XPRSTREPA-10, represents procurement under a broader contracting vehicle and carries no set-aside designation. Cepheid is a specialized manufacturer of advanced molecular diagnostic systems and...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a firm fixed-price delivery order valued at $1,190.28 from the Defense Logistics Agency (DLA), which operates under the Medical Supply Chain function. The contract, awarded on September 11, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This delivery order is executed under a larger indefinite delivery vehicle (IDV) contract structure, enabling...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,597.30 by the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order, issued under contract number 4570439578, represents a child contract with no set-aside designation. As a leading manufacturer of advanced molecular diagnostic systems and reagents, Cepheid will deliver diagnostic solutions in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,595.60 by the Defense Logistics Agency Medical Supply Chain under contract number 4570185677. This firm fixed-price delivery order, issued on December 4, 2025, with an ultimate completion date of December 11, 2025, represents an order for diagnostic supplies and reagents supporting the agency's molecular diagnostics capabilities. The award utilizes no set-aside designation, reflecting Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,220 on January 6, 2026, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, designated GXMRSA-NXG-10, is scheduled for completion by January 13, 2026, and carries no set-aside designation. The award represents a continuation of the company's extensive federal contracting relationship as a primary supplier of molecular...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F00DUDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, received a delivery order valued at $4,791.90 from the Defense Logistics Agency's Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order, issued under contract GXCT/NG-10, represents a child contract with no set-aside designation. The order falls under Cepheid's established relationship with DLA as a primary federal supplier of molecular diagnostic systems and reagents, leveraging the company's GeneXpert diagnostic platform and associated testing capabilities. As a recognized leader in infectious disease diagnostics, Cepheid has demonstrated substantial capability across multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds significant indefinite delivery contracts with the VA, including a $32.8 million agreement with VISN 6 extending through September 2030, which establishes the framework for ongoing procurement of diagnostic reagents, test kits, and molecular testing system assays. This DLA delivery order represents continued federal reliance on Cepheid's diagnostic solutions to support defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/8/26 |